Abstract
Renal transplantation is associated with increased incidence of cancer. We reviewed a large series of renal transplant recipients to determine the incidence and outcome of patients with malignant changes located at the head and neck. A total of 1232 renal transplant recipients have been followed at Department of Dialysis University Hospital Centre Zagreb from 1972 to 2009. Demographic data, localization and disease outcome were evaluated in patients who developed cancer. Twenty one patients (1.7%) developed 27 head and neck malignancies. The average time from transplantation to development of cancer was 56.8 months. The mean length of follow-up was 9.4+/-4.8 years. Eighteen malignancies were cutaneous in origin and 9 were noncutaneous. Of cutaneous malignancies, 88.9% were basal cell carcinoma; one patient had Merkell-cell carcinoma and one patient developed squamous cell carcinoma. Six cases of basocellular skin cancer were recorded in one fair-skin patient. Noncutaneous malignancies involved the oral cavity (2 cases of Kaposi's sarcoma and one pharyngeal cancer) and the thyroid gland in 3 patients each. Two patients had post-transplant lymphoproliferative disorder occurring at the head and neck. One patient had brain tumor. Radical surgery, radiation, and/or chemotherapy were necessary in 33.3% of patients. Immunosuppression was reduced in all patients, and 12 patients were switched from the calcineurin-based immunosuppression to sirolimus. They all have stable graft function. None of the patients died from cancer. Immunosuppression was ceased in one patient with Kaposi's sarcoma who returned to dialysis and died 10 years later from heart failure. An increased incidence of cancer occurring in the head and neck was recorded. Careful skin examination and oral examination is mandatory for discovering cancer before dissemination. Sirolimus is safe alternative to calcineurin-based immunosuppression in patients who developed head and neck malignancies.
Highlights
Kidney transplantation is the method of choice for treatment of patients with the end-stage renal disease (ESRD)
Few studies have reported on the rate of head and neck malignancies in renal transplant population
In the present study we examined prevalence, clinical characteristics and outcome of head and neck malignancies occuring in renal transplant recipients in Croatia
Summary
Kidney transplantation is the method of choice for treatment of patients with the end-stage renal disease (ESRD). Prolonged immunosuppression is associated with increased incidence of malignant diseases ( ). Malignancies of the head and neck may occur in kidney transplant recipents, or they may develop de novo ( ). Tumors occur more often and behave clinically more aggressive in renal transplant recipients than in the general population ( ). E overall incidence of different malignancies in this population ranges from to ( ). Few studies have reported on the rate of head and neck malignancies in renal transplant population. In the present study we examined prevalence, clinical characteristics and outcome of head and neck malignancies occuring in renal transplant recipients in Croatia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.